Facing Regulatory, Reimbursement Changes, Pharmacy Execs Also See Opportunities

Why It Matters

These dynamics directly affect health‑system revenue, patient access to high‑cost therapies, and the competitive positioning of pharmacy operations in a rapidly evolving care landscape.

Key Takeaways

• Specialty pharmacy faces payer, manufacturer, capacity barriers.
• Home infusion market projected to double by 2034.
• AI streamlines prior authorizations, reduces claim denials.
• 340B rebate model adds compliance complexity.
• Pharmacists now required to blend clinical and business expertise.

Pulse Analysis

The pharmacy function is evolving from a dispensing unit to a strategic hub that links clinical, financial, and operational teams. As specialty drugs become more complex and costly, health systems rely on pharmacists to negotiate payer contracts, secure manufacturer allocations, and design patient‑centric workflows. This shift requires leaders who can speak the language of both clinicians and C‑suite executives, positioning pharmacy as a revenue‑generating, value‑based service rather than a cost center.

Regulatory pressures, especially around the 340B program and the now‑shelved rebate‑model pilot, have introduced new compliance layers that strain existing resources. Payers often direct patients to external pharmacies, eroding in‑house capture rates, while manufacturers impose limited‑distribution constraints. To mitigate these hurdles, organizations are adopting AI‑enabled prior‑authorization platforms that auto‑populate forms, flag eligibility issues, and accelerate claim adjudication, thereby reducing denial rates and freeing staff for direct patient care.

Meanwhile, the home‑infusion market is set to surge from $15.1 billion in 2025 to $31.4 billion by 2034, driven by consumer demand for convenient care and payer incentives for lower‑cost settings. Tech‑enabled, team‑based models that combine automated workflow engines with skilled pharmacists enable rapid scaling of these services. Companies like Cencora’s Accelerate Pharmacy Solutions provide the infrastructure—people, technology, and accreditation support—to help health systems capture this growth while maintaining compliance and financial performance.